| CTRI Number |
CTRI/2025/12/099837 [Registered on: 26/12/2025] Trial Registered Prospectively |
| Last Modified On: |
24/12/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Medical Device |
| Study Design |
Cluster Randomized Trial |
|
Public Title of Study
|
A comparison of outcomes between Opioid based Vs Non-Opioid based (Subarachnoid blockade) in General Anesthesia in participants posted for Laparoscopic Hysterectomy by QoR 15 Assessment |
|
Scientific Title of Study
|
A comparison of Opioid based Vs Non-Opioid based (Subarachnoid blockade) in General Anesthesia for Laparoscopic Hysterectomy: QoR 15 Assessment |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
DR PRIYA CHAVRE |
| Designation |
ASSISTANT PROFESSOR |
| Affiliation |
PCMC PGI YCM HOSPITAL |
| Address |
DEPARTMENT OF ANAESTHESIA,
DHANVANTARI OT, FIRST FLOOR,
PCMC PGI YCM HOSPITAL, PIMPRI, PUNE
Pune MAHARASHTRA 411018 India |
| Phone |
9405425407 |
| Fax |
|
| Email |
priyachavre93@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DR PRIYA CHAVRE |
| Designation |
ASSISTANT PROFESSOR |
| Affiliation |
PCMC PGI YCM HOSPITAL |
| Address |
DAPARTMENT OF ANAESTHESIA
DHANVANTARI OT, FIRST FLOOR,
PCMC PGI YCM HOSPITAL, PIMPRI, PUNE
Pune MAHARASHTRA 411018 India |
| Phone |
9405425407 |
| Fax |
|
| Email |
priyachavre93@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
DR PRIYA CHAVRE |
| Designation |
ASSISTANT PROFESSOR |
| Affiliation |
PCMC PGI YCM HOSPITAL |
| Address |
DEPARTMENT OF ANAESTHESIA
DHANVANTARI OT , FIRST FLOOR PCMC PGI YCM HOSPITAL, PIMPRI, PUNE
Pune MAHARASHTRA 411018 India |
| Phone |
9405425407 |
| Fax |
|
| Email |
priyachavre93@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
PCMC PGI YCM HOSPITAL |
| Address |
PCMC PGI YCM HOSPITAL PIMPRI PUNE |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DR PRIYA CHAVRE |
PCMC PGI YCM HOSPITAL |
DEPARTMENT OF ANAESTHESIA, DHANVANTARI OT , FIRST FLOOR Pune MAHARASHTRA |
9405425407
priyachavre93@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| ETHICS COMMITTE, PCMCS PGI YCM HOSPITAL |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: N859||Noninflammatory disorder of uterus, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
General Anaesthesia |
General Anesthesia will be standardized across both groups with premedications and neuromusclcular agent Vecuronium Inhalational agent Isoflurane and maintenance on oxygen and Nitrous oxide at 50%. The patient will be reversed at the end of the procedure wuth neostigmine and glycopyrrolate. |
| Comparator Agent |
Spinal Anaesthesia |
Spinal Anaesthesia will be given in one group at L3-L4 interspace using 2.6cc of Isobaric 0.5% Bupivacaine. In another group only General Anaesthesia will be given. |
|
|
Inclusion Criteria
|
| Age From |
40.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Female |
| Details |
ASA I and II females scheduled for laparoscopic hysterectomy |
|
| ExclusionCriteria |
| Details |
ASA III and IV
Patients posted for revision or complicated surgery
|
|
|
Method of Generating Random Sequence
|
Stratified block randomization |
|
Method of Concealment
|
On-site computer system |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
To assess the effects of Non opioid based spinal General Anesthesia versus Opioid based General Anesthesia on the QoR-15 in patients undergoing laparoscopic hysterectomy.
|
At baseline, after 1 hour , 12 hours and 24 hours post surgery |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To compare hemodynamic parameters in both groups |
At baseline, at post spinal, post intubation, at pneumoperitonuem insufflation, during surgery at 5,30,60,90,120 & 150 minuttes interval. |
| To assess consumption of inhalational agent in both the groups |
Intraoperatively |
| To assess time of regression & time of first rescue analgesia in both the groups |
24 hours postoperatively |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
05/01/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - For individual participant data meta-analysis.
- By what mechanism will data be made available?
Response - Proposals should be directed to [priyachavre93@gmail.com].
- For how long will this data be available start date provided 15-11-2025 and end date provided 15-11-2030?
Response - Beginning 3 months and ending 5 years following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - nil
|
|
Brief Summary
|
Patients undergoing Laparoscopic Hysterectomy will be assigned into two groups randomly after CTRI and IEC approval. To study and compare QoR-15 scores between Non-Opioid based Spinal General Anaesthesia and Opioid based General Anaesthesia in patients undergoing Elective Laparoscopic Hysterectomy Preoperatively Age Weight Height ASA I OR II BMI QOR-15 will be recorded Parameters Prior To Induction Heart Rate Systolic And Diastolic Blood Pressure Mean Arterial Pressure And Saturation Spo2 will be taken. In one group Patients will be given spinal anesthesia in sitting position and after achieving T4 level they will be given General Anesthesia. In other group patients will be given General Anesthesia with Injection Fentanyl. Intraoperatively following parameters will be monitored Heart rate Systolic blood pressure Diastolic blood pressure Mean arterial pressure Oxygen Saturation MAC ETCO2 at post spinal post intubation at pneumoperitoneum insufflation during surgical manipulation at 5 30 60 90 120 150 min intervals at desufflation at extubation and recovery. QOR-15 will be assessed at baseline and postoperatively at 1hr 12hrs 24hrs interval after the surgery |